Lipid Emulsion Inhibits Amlodipine-Induced Nitric Oxide-Mediated Vasodilation in Isolated Rat Aorta

Int J Mol Sci. 2023 May 14;24(10):8741. doi: 10.3390/ijms24108741.

Abstract

This study aimed to examine the effect of lipid emulsion on the vasodilation induced by a toxic dose of amlodipine in isolated rat aorta and elucidate its mechanism, with a particular focus on nitric oxide. The effects of endothelial denudation, NW-nitro-L-arginvine methyl ester (L-NAME), methylene blue, lipid emulsion, and linolenic acid on the amlodipine-induced vasodilation and amlodipine-induced cyclic guanosine monophosphate (cGMP) production were examined. Furthermore, the effects of lipid emulsion, amlodipine, and PP2, either alone or combined, on endothelial nitric oxide synthase (eNOS), caveolin-1, and Src-kinase phosphorylation were examined. Amlodipine-induced vasodilation was higher in endothelium-intact aorta than in endothelium-denuded aorta. L-NAME, methylene blue, lipid emulsion, and linolenic acid inhibited amlodipine-induced vasodilation and amlodipine-induced cGMP production in the endothelium-intact aorta. Lipid emulsion reversed the increased stimulatory eNOS (Ser1177) phosphorylation and decreased inhibitory eNOS (Thr495) phosphorylation induced via amlodipine. PP2 inhibited stimulatory eNOS, caveolin-1, and Src-kinase phosphorylation induced via amlodipine. Lipid emulsion inhibited amlodipine-induced endothelial intracellular calcium increase. These results suggest that lipid emulsion attenuated the vasodilation induced via amlodipine through inhibiting nitric oxide release in isolated rat aorta, which seems to be mediated via reversal of stimulatory eNOS (Ser1177) phosphorylation and inhibitory eNOS (Thr495) dephosphorylation, which are also induced via amlodipine.

Keywords: amlodipine; lipid emulsion; nitric oxide; toxicity; vasodilation.

MeSH terms

  • Amlodipine* / toxicity
  • Animals
  • Aorta
  • Fat Emulsions, Intravenous* / pharmacology
  • Female
  • In Vitro Techniques
  • NG-Nitroarginine Methyl Ester / pharmacology
  • Nitric Oxide Synthase Type III / metabolism
  • Nitric Oxide* / metabolism
  • Phospholipids* / pharmacology
  • Soybean Oil* / pharmacology
  • Vasodilation*
  • Vasodilator Agents* / toxicity

Substances

  • Fat Emulsions, Intravenous
  • Nitric Oxide
  • Amlodipine
  • Vasodilator Agents
  • NG-Nitroarginine Methyl Ester
  • soybean oil, phospholipid emulsion
  • Phospholipids
  • Soybean Oil
  • Nitric Oxide Synthase Type III